483 Shenzhen Oriental Pharmaceutical Jun 2016

483 Shenzhen Oriental Pharmaceutical Jun 2016

$119 - Not in Stock

FDA investigators audited the Shenzhen Oriental Pharmaceutical - Shenzhen, China facility and issued inspectional observations (via FDA 483) on 07 Jun 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 07 Jun 2016
  • Location: Shenzhen, China
  • FEI: 3003677845

Pre-Order Not Available